A recent paper by Boal Carvalho et al demonstrates the potential of Pill Cam COLON 2?(PCC2) as a panenteric investigation in Crohn’s disease(CD). Our own prospective data in patients with known CD also shows good correlation between PCC2 and small/large bowel investigations(R = 0.896,P < 0.0004/R = 0.6667,P <0.035). Larger studies are warranted to prospectively validate the use of PCC2 in the investigation and monitoring of both small and large bowel CD.